Tabrecta Tablet, Film Coated
Product Images NDC 0078-0709

3 FDA label images from Novartis Pharmaceuticals Corporation · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tabrecta (NDC 0078-0709). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Capmatinib Structural Formula (Inc280 01)

Capmatinib Structural Formula (Inc280 01)
Chemical structure diagram of capmatinib, the active ingredient in TABRECTA tablets, showing molecular connections and components including a fluorinated aromatic ring and heterocyclic groups.*
FDA Label Image

Principal Display Panel Ndc 0078-0709-56 Tabrecta™ (capmatinib) Tablets 150 mg* Attention: Dispense And Store Tabrecta In Original Container With The Desiccant To Protect From Moisture. Rx Only 56 Film-coated Tablets Novartis (Inc280 02)

Principal Display Panel Ndc 0078-0709-56 Tabrecta™ (capmatinib) Tablets 150 mg* Attention: Dispense And Store Tabrecta In Original Container With The Desiccant To Protect From Moisture. Rx Only 56 Film-coated Tablets Novartis (Inc280 02)
Label for TABRECTA (capmatinib) 150 mg film-coated oral tablets by Novartis Pharmaceuticals Corporation. The package contains 56 tablets and includes storage instructions, caution to dispense in original container with desiccant, and notes to keep out of reach of children. The label shows the NDC 0078-0709-56 and includes a barcode and expiration/lot number area.*
FDA Label Image

Principal Display Panel Ndc 0078-0716-56 Tabrecta™ (capmatinib) Tablets 200 mg* Attention: Dispense And Store Tabrecta In Original Container With The Desiccant To Protect From Moisture. Rx Only 56 Film-coated Tablets Novartis (Inc280 03)

Principal Display Panel Ndc 0078-0716-56 Tabrecta™ (capmatinib) Tablets 200 mg* Attention: Dispense And Store Tabrecta In Original Container With The Desiccant To Protect From Moisture. Rx Only 56 Film-coated Tablets Novartis (Inc280 03)
Label for TABRECTA (capmatinib) tablets 200 mg film-coated oral tablets by Novartis Pharmaceuticals Corporation. The label includes the NDC 0078-0716-56, quantity of 56 tablets, storage and handling instructions, recommended dosage note, and reminder to discard unused tablets 6 weeks after opening. Product is Rx only and made in Ireland.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.